Sol-Gel Technologies (SLGL) Other Non-Current Assets (2018 - 2025)

Sol-Gel Technologies' (SLGL) quarterly Other Non-Current Assets came in at $62000.0 in Q4 2025, up 376.92% year-on-year from $13000.0 in Q4 2024, and down 94.76% on a QoQ basis from $1.2 million in Q2 2025.

Sol-Gel Technologies (SLGL) Other Non-Current Assets (2018 - 2025) Analysis & Trends

Sol-Gel Technologies (SLGL) has 8 years of Other Non-Current Assets data on file, last reported at $62000.0 in Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 376.92% year-over-year to $62000.0 in Q4 2025; TTM through Dec 2025 was $62000.0, a 376.92% increase from a year earlier, with the FY2025 full-year figure at $62000.0, up 376.92% from the prior year.
  • Other Non-Current Assets for Q4 2025 stood at $62000.0, down from $1.2 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for SLGL reached as high as $1.5 million in Q3 2024 and fell as low as $13000.0 in Q4 2024.
  • Historically, Other Non-Current Assets has averaged $739444.4 across 5 years, with a median of $1.2 million in 2021.
  • Across the five-year window, Other Non-Current Assets plunged 96.29% in 2024 and soared 376.92% in 2025, its largest moves.
  • Year by year, Other Non-Current Assets stood at $1.2 million in 2021, then changed by 0.0% to $1.2 million in 2022, then tumbled by 69.57% to $350000.0 in 2023, then plunged by 96.29% to $13000.0 in 2024, then surged by 376.92% to $62000.0 in 2025.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $62000.0 in Q4 2025, $1.2 million in Q2 2025, and $13000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Sol-Gel Technologies 227.58 Mn 217.44 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 62,000.00
Jun 30, 2025 1.18 Mn
Dec 31, 2024 13,000.00
Sep 30, 2024 1.54 Mn
Jun 30, 2024 1.16 Mn
Mar 31, 2024 45,000.00
Dec 31, 2023 350,000.00
Dec 31, 2022 1.15 Mn
Dec 31, 2021 1.15 Mn
Dec 31, 2020 1.15 Mn
Dec 31, 2019 350,000.00
Dec 31, 2018 350,000.00